Osteoarthritis (OA) is a whole joint disease driven by abnormal biomechanics and attendant cell-derived and tissue-derived factors. The disease is multifactorial and polygenic, and its progression is significantly related to oxidative stress and reactive oxygen species (ROS). Augmented ROS generation can cause the damage of structural biomolecules of the joint and, by acting as intracellular signaling component, ROS are associated with various inflammatory responses. By activating several signaling pathways, ROS have a vital importance in the patho-physiology of OA. This review is focused on the mechanism of ROS which regulate intracellular signaling processes, chondrocyte senescence and apoptosis, extracellular matrix synthesis and degradation, along with synovial inflammation and dysfunction of the subcondral bone, targeting the complex oxidative stress signaling pathways.
Introduction
Arthritis is a chronic joint disease leading to cartilage degradation that involves synovial inflammation, subchondral bone remodeling and the formation of osteophytes [1, 2] . Cartilage degradation results from ruptured joint homeostasis that favors catabolic processes. These processes are activated by pro-inflammatory mediators such as cytokines, lipid mediators and reactive oxygen species (ROS), which are produced also by chondrocytes, synoviocytes and osteoblasts [3, 4] . These products are responsible for battering anabolism and release of proteolytic enzymes, degrading the extracellular matrix.
The definition of oxidative stress as a disturbance in the pro-oxidant/antioxidant balance in favor of the former [5] implies that this disturbance can be corrected by the addition of appropriate anti-oxidants. Redox mechanisms have been shown to influence intracellular signaling and cells seem to be very sensitive to the loss of these regulatory and control systems [6, 7] .
Previous studies demonstrated that osteoarthritis (OA) progression is significantly related to oxidative stress and ROS [8, 9] . OA is characterized by morphological, biochemical, molecular and biomechanical changes of both cells and extracellular matrix (ECM) which leads to softness, loss of articular cartilage, synovial inflammation, sclerosis of subchondral bone, formation of osteophytes and subchondral cysts ( Figure 1 ).
In this review we aim to summarize the knowledge about the contribution of the oxidative stress signaling pathways to OA pathobiology.
Mechanical stress
Under normal physiological conditions, the synovial space is one of the most pressurized areas of the body. Classical stress factors are present in the synovial cavity, and these stimuli are likely to influence the functions of the synovial membrane cells. Like the blood vessels walls, the synovial cavity is exposed to a high degree of mechanical stress in normal and pathological conditions. In addition to mechanical stresses, there is also oxidative stress that follows the cutting forces. In particular, the movement of the synovial fluid induces shear forces whose biophysics has been studied in detail [10] [11] [12] . Because the cells transduce mechanical stress into biochemical signals, many cellular functions can be affected by the presence of mechanical stress.
, rather than to water. The NADPH oxidase enzymes (NOXes) are the major sources of ROS in phagocytes through the reaction 2O 2 + NADPH → 2O 2 − + NADP + + H + . Upon stimulation, cytosolic components translocate to the inner face of the plasma membrane to form a fully active enzyme complex that possesses NADPH oxidase activity. A similar process is believed to take place in non-phagocytic cells as well. XO catalyzes the oxidation of hypoxanthine to xanthine, producing H 2 O 2 [13, 14] .
The major sites of ROS production include the mitochondria -through oxidative phosphorylation, nonmitochondrial membrane-bound nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and xanthine oxidase (XO) [14] [15] [16] .
Extensive mechanisms for scavenging ROS have evolved into species that utilize oxygen for energy production. This antioxidant system includes enzymatic and non-enzymatic antioxidants, such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), glutathione (GSH), NADPH ubiquinone oxidoreductase (NQO 1 ), paraoxanases (PON), ascorbic acid (vitamin C), alfa-tacopherol (vitamin E) and carotinoid [17, 18] .
The free radical NO -is produced by a number of different cell types with a variety of biological functions. NO -is a product of the oxidation of l-arginine to l-citrulline in a two steps process catalysed by the enzyme nitric oxide synthase (NOS). Three major isoforms of NOS have been identified. The constitutive isoforms found in neurons and endothelial cells, namely neuronal NOS (nNOS) and endothelial NOS (eNOS), produce very low amounts of NO in a calcium-and calmodulin-dependent fashion. The inducible isoform of the enzyme (iNOS), is expressed for a longer period of time, requires minimal concentrations of calcium, produces NO in relatively large amounts in response to proinflammatory cytokines lipopolysaccharide (LPS), interleukin-1 (IL-1), tumoral necrosis factor-α (TNF-α), interferon-γ (IFN-γ) and acts in a host defensive role through its oxidative toxicity. Regardless of the source/role, NO reacts with several different molecules that are normally present to form either nitrate (NO 3 -) or nitrite (NO 2 -) [19] . Reactive nitrogen species (RNS), a family of molecules derived from NO -and O 2 -, are responsible of the nitrosative stress that act together with ROS in the process of cell damage [20] .
ROS function
ROS are known to be a component of the killing response of immune cells to bacterial invasion. The stimulated production of ROS by phagocytic cells, catalyzed by NADPH oxidase, was originally called "the respiratory burst" because of the increased consumption of oxygen by these cells [21] . It is known that ROS are produced in all cell types and serve as important cellular messengers in normal signal transduction, gene regulation, and cell cycling [22] .
ROS-induced cell signaling involves two general mechanisms: alterations in the intracellular redox state and oxidative modification of proteins. Cells respond to ROS in different ways depending on the intensity, duration, context of the signaling and cellular redox status. When the oxidant level does not exceed the reducing abilities of cells, ROS are involved in several physiological cellular functions including signal transmission [22] . It is now apparent that a very complex intra-cellular regulatory system involving ROS exists within cells [23] .
After its production, ROS mediates its biological activities, which can be divided into three categories. Firstly, ROS reacts with transition metals (Fe, Cu, Zn), which are abundant in prosthetic groups of enzymes, regulating their activity. NO activates soluble hemecontaining cyclic guanylate cyclase (sGC) to produce activated cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). cGMP acts a second messenger as it specifically binds to target proteins which include cGMP-dependent protein kinases (PKG), cAMPdependent protein kinases phosphodiesterases (PDEs) and cyclic nucleotide-gated channels to elicit a number of biological effects [24, 25] . Simultaneously, NO inhibits Cucontaining cytochrome P-450 enzymes and cytochrome c oxidase in mitochondria, and Fe-containing CAT, resulting in a reduction of the electron transport chain favoring the formation of O 2 − and H 2 O 2 [26] . Secondly, ROS can also bind to a reactive cysteine thiol to form S-nitrosothiols, which are very important regulators of physiology and pathology, affecting the activity of enzymes and transcription factors, such as NF-κB, AP-1, p21 kinase, c-Jun N-terminal kinases (JNKs), caspase-3 and caspase-9, through prevalent post-translational protein modification [27] . Under physiologic conditions, protein S-nitrosylation and S-nitrothiosols provide protection preventing further cellular oxidative and nitrosative stress.
Thirdly, ROS production in an oxidizing environment, as when O 2 − is present, leads to the rapid formation of reactive molecules such as peroxynitrite (ONOO − ). ONOO − is rapidly decomposed to NO 2 and OH − and all together they react with other molecules and radicals. At cellular pH, ONOO − is protonated to form peroxynitrous (ONOOH) which is very cytotoxic, causing depletion of − SH groups, oxidation of lipids, DNA strand breakage and deamination of DNA bases [25] . NO can also act in a cGMP-independent manner, by directly modifying proteins or contributing to the oxidation of proteins and lipids, further increasing the complexity and number of potential roles for NO in cellular functions [28] .
ROS signaling in OA cartilage
Besides other agents -risk factors such as overweight or a family history, oxidative stress is involved in the pathogenesis of OA. OA is not limited to articular cartilage only, but also affects the subchondral bone, as well as the adjacent connective tissue and the synovial membrane. The involvement of free radicals in signal transduction highlighted that, within evolution, higher life forms took advantage of the ability of ROS to mediate signals over cell margins in a system consisting of discrete compartments like joints. Because of their chemical properties, free radicals meet the requirements to mediate and amplify the characteristic sequence of joint degeneration in all tissues affected. ROS are crucial factors in the OA pathophysiology and the sudden breakdown of compensation leading to inflammatory transformation of OA joints.
ROS production in chondrocytes
ROS are produced at low level in chondrocytes, mainly by NADPH oxidase, and they act as integral actors of intracellular signaling mechanisms, contributing to the maintenance of cartilage homeostasis as they modulate chondrocyte apoptosis, gene expression, extracellular matrix (ECM) synthesis/breakdown and cytokine production [29] [30] [31] [32] [33] (Figure 2 ). ROS production and oxidative stress were found elevated in patients with OA [34] [35] [36] . Evidence for ROS implication in cartilage degradation came from the presence of lipid peroxidation products, such as oxidized low-density lipoprotein (ox-LDL), nitrite (NO 2 -), nitrotyrosine, and nitrated (NO 3 -) products in the biological fluids and the cartilage of OA patients with and in OA animal models [28, [32] [33] [34] [35] . On the contrary, antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) were decreased in OA patients, confirming the role of oxidative stress in OA pathogenesis [30, 31, [36] [37] [38] [39] [40] .
Superoxide anion radicals are produced by NADPH oxidase, whose components are expressed in human articular chondrocytes [41] [42] [43] . It was demonstrated that the porcine articular chondrocytes can release ROS using the NADPH oxidase-like complex [40] . NADPH oxidase expressed by chondrocytes is the main enzyme responsible for ROS formation in synovial fluid, contributing to increased oxidative stress inside the joint and mediating the progressive cartilage degradation of OA [42] [43] [44] [45] .
Nitric oxide synthase isoform (iNOS) is mainly expressed in human chondrocytes [44] and its expression is upregulated by inflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-17 (IL-17), tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), and shear stress [46] . Chondrocytes from OA cartilage overexpress NOS particularly in the superficial zone, suggesting that these tissues are actively producing iNOS [47] . The role of NOS in OA pathogenesis is supported by the fact that NOS knockout mice do not develop experimental OA [48] .
Apart from iNOS, another NOS isoform, neuronal nitric oxide synthase (nNOS), which produces lower amounts of NO, was found to be constitutively expressed in bovine chondrocytes and to be degraded in response to IL-1. The presence of a protein similar in size and antibody binding to nNOS, but with enzymatic activity of iNOS has been reported in human OA chondrocytes. Since NO is recognized as a major factor in OA progression, iNOS inhibitors have been considered as potential candidates for disease modification. It is known that selective inhibition of iNOS retards the progression of experimental arthritis. There is a study that investigated the clinical utility of selective iNOS inhibitors as disease-modifying OA drugs, as they have been shown to reduce joint inflammation and erosion in animal models of OA. The same study demonstrated that nNOS is more frequently expressed by normal chondrocytes, while iNOS prevails in OA chondrocytes [49] .
Chondrocytes are quiescent and lack self-renewal capacity. Chondrocyte death is regarded as a major factor in OA pathogenesis and oxidative stress seems to play a major role through chondrocyte apoptosis [50] . Apoptosis is a complex intracellular pathway resulting from the equilibrium between apoptotic and non-apoptotic factors and processes [51] . The mechanism of apoptosis are divided into the intrinsic or mitochondrial pathway, which is induced by intracellular signals, and the extrinsic or death receptor pathway, which is triggered by the extracellular signals, including activation of the death receptor family. However, the two apoptosis pathways are interconnected through the mitochondria.
The extrinsic pathway involves transduction of the apoptotic signal after the binding of death receptors, such as Fas, TNF receptor 1 (TNFR1) or TNF-related apoptosis inducing ligand (TRAIL) receptor R1 and R2, to their ligands FasL, TNF and TRAIL.
Excess production of ROS and NO has been linked with apoptosis of cartilage chondrocytes both in vitro and in vivo and apoptotic chondrocytes in OA are reported to contain 3-nitrotyrosine [52, 53] .
H 2 O 2 induces chondrocyte cell death in a dosedependent way [54] . ROS induces chondrocyte apoptosis through regulation of PI3K/Akt and JNK signaling pathways. Increased oxidative stress makes chondrocytes more susceptible to oxidant-mediated cell death though the deregulation of the glutathione antioxidant system [55] . H 2 O 2 generated by the hypoxanthine-xanthine oxidase (XOD) system leads to inhibition of growth of articular chondrocytes. In addition, a product of lipid peroxidation causes human chondrocyte death by activating caspase-3, -9 and suppressing pro-survival AKT kinase activity [56] .
The precise role of NO in the induction of chondrocyte death is repeatedly disputed. NO is the primary inducer of chondrocyte apoptosis, mediated by caspase-3, caspase-9 and tyrosine kinase activation which cause iNOS upregulation [57] [58] [59] , but the action of ONOO -is also required [60] . Addition of ONOO − to articular chondrocytes has been found to lead to apoptotic death. NO-induced apoptosis of chondrocytes depends on the crosstalk between iNOS and COX-2 systems, which is linked to the activation of MEK1/2 and p38 pathways. However, production of high levels of endogenous NO by overexpression of the iNOS gene in transfected chondrocytes has not been found to cause cell death [60] . This discrepancy might be the result of using chemical NO donors, which produce various secondary reactions depending on the cellular milieu in in vitro experiments.
Sodium nitroprusside (SNP) is generally regarded as the donor of NO to study the mechanism of chondrocyte NO-induced apoptosis [61] . In vitro, SNP induces apoptotic events in chondrocytes by increasing caspase-3 and caspase-7 expression and downregulating Bcl-2 expression [62] . It has been found that in human chondrocytes, SNP induces DNA fragmentation, cytoskeletal remodeling, mitochondrial dysfunction, caspase activation and cytochrome C release, all of which are apoptotic events [63] .
NO also appears to mediate chondrocyte apoptosis driven by chronic mechanical overloading of joints. In response to chronic mechanical overloading, both in vivo and in vitro, chondrocytes generate high levels of NO, and this production depends on the oxygen tension within articular cartilage [64, 65] . However, it is important to note that SNP binds to oxyhemoglobin to release NO.
On the other hand, other studies propose that NO -is a physiologic regulator of mitochondrial respiration [62, 64] or it may have an anti-protein activity, via the inhibition of as-induced caspase-3 activation, especially when intracellular antioxidant level is very low [64, 65] . The pro-apoptotic effect of IL-1β does not depend on NO - [65] and NO -mediated chondrocyte cell death demands the generation of additional ROS [37, 66] . Apoptosis is a consequence of cell inactivation, following the induction of deoxyribonucleic acid (DNA) damage [67] .
As both the predominant site for ROS production and the prime target of these molecules, mitochondria play a key role in oxidative stress and in OA pathogenesis. ROS cause mitochondrial respiratory chain inhibition, adenosine triphosphate (ATP) decrease, and mitochondrial DNA (mtDNA) mutation all of which are related to the severity of the inflammatory process as they enhance functional failure and cell death [65, 68, 69] (Figure 3 ).
Functions of ROS in the articular cartilage
Chondrocytes comprise 2-5% of the cartilage volume, a tissue that is avascular and lacks innervation. In normal conditions, the adult articular chondrocyte is a resting cell, with no detectable mitotic activity, and adapted to an environment with low oxygen supply. For these reasons the intracellular metabolism is constant, and the turnover synthesis of ECM components is low. Despite the traditional opinion that chondrocytes live in an anaerobic environment, the superficial and middle zones of articular cartilage are not anoxic; oxygen does diffuse into articular cartilage, and articular chondrocytes possess mitochondria and breath in vitro, producing ROS [70] .
In pathological situations, such as in OA, oxygen tension in synovial fluid is subjected to fluctuations because of ischemia-reperfusion phenomenon, pathological acceleration of tissue metabolism and sustained abnormal strains on the joint [71] . In response to partial oxygen pressure variations, mechanical stress [55, 72] and inflammatory mediators (IL-1β, IFN-γ, ox-LDL, LPS, IL-17), the chondrocytes produce abnormal levels of ROS through NADPH oxidase, NOS and XO [40, 73, 74] .
In chondrocytes, ROS intermediates in multiple signaling pathways including those initiated by cytokines, growth factors and ECM proteins. The responses of the cells to cytokines and growth factors depend on the cell redox status which is a result of a subtle equilibrium between ROS production and the intracellular antioxidants level. This balance is subtly modulated by exogenous factors, such as oxygen tension or cytokines. In pathological circumstances, such as in OA, the redox status can be altered and the responses of the cells to biochemical factors can be fully modified [75, 76] . ROS have been implicated in the inhibition of new cartilage ECM synthesis, leading to loss of cartilage integrity. Cartilage ECM is primarily composed by type II collagen (COLII) and proteoglycans (PGs) [68] . In cultures of human articular chondrocytes, endogenously produced O -inhibited the synthesis of proteoglycans from both the superficial and deep cartilage zone. Inside chondrocytes, H 2 O 2 suspends proteoglycan synthesis by suppressing the mitochondrial oxidative phosphorylation and adenosine triphosphate (ATP) formation [77, 78] . The concurrent generation of O 2 − and NO -is required for IL-1 to inhibit proteoglycan synthesis [79] . Oxidative stress inhibits IGF-1 induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidyl inosite-3-kinase (PI3K/Akt) and extracellular signalregulated-kinase (MEK-ERK) signaling pathways [50, 80] . NO -is implicated in the IL-1-dependent inhibition of COLII and aggrecan synthesis [81] . NO -blocks biosynthesis of COLII at a post-translational level by activating prolyl hydroxylase and therefore inducing the hydroxylation of proline residues. This fact is counteracted by the presence of hyaluronic acid (HA) in synovial fluid which inhibits IL-1β-stimulated NO -synthesis [82] . In terms of new cartilage synthesis, ROS contribute to the loss of chondrocyte sensitivity to growth factors [83] . ROS may also participate in the failure to recover by reducing the capacity of chondrogenic precursor cells to migrate and proliferate within an injured area [79] . Similarly, NO -has been demonstrated to inhibit chondrocyte migration and attachment to fibronectin via modification of the actin cytoskeleton [84] .
ROS signaling in synovial inflammation
The inflammatory reaction in synovium is controlled by several biochemical factors, including prostanoids, cytokines (IL-1α, IL-1β, TNF-α, PGE2), proteases and ROS produced by both synoviocytes and chondrocytes. ROS contribute to the inflammatoryrelated tissue degradation and are classically defined as partially reduced metabolites of oxygen that possess strong oxidizing capabilities. They are injurious, because they oxidize protein and lipid cellular constituents and damage the DNA. ROS function as signaling molecules that regulate cell growth, the adhesion of cells toward other cells, differentiation, senescence, and apoptosis [85, 86] . The concept of chronic or prolonged ROS production is considered central to the progression of inflammatory disease. NO regulates the LPS activated signaling pathway, while the IL-1β activated transduction factors are more sensitive to ONOO - [87] . In synovial fibroblasts, ROS have also been shown to be required for signaling initiated through the integrin [88] .
Oxidative stress, and especially O 2 − , causes synoviocyte apoptosis in vitro through mitochondrial injury [86] . Similarly, NO -reduces the survival and induces cell death of OA synoviocytes by regulating mitochondrial functionality [88, 89] . However, high NO levels can induce synovial cells apoptosis only when cell capacities to repair DNA damage are exceeded [90] . Furthermore, NO -induces OA synovial fibroblast apoptosis through activation of caspase-3, caspase-9 and upregulation of cyclooxygenase-2 (COX-2) expression. The NO -induced cell death is strongly associated with the production of ONOO − , H 2 O 2 and O 2 − [91] (Figure 4) . Soft tissues such as menisci and infrapatellar pad play a crucial role in knee OA pathogenesis. A meniscal tear can lead to knee OA, but knee OA can also lead to a spontaneous meniscal tear through breakdown and weakening of the meniscal structure [92] . iNOS and NO -production by meniscal cells is increased in OA, as NO -augments apoptosis of meniscal cells via inhibition of autophagy through inactivation of c-Jun N terminal kinase 2 (JNK2) [93, 94] . The infrapatellar fat pad is an emerging source of inflammatory and adipokines that contributes to knee OA progression [95] . It is known that adipose dysfunction and metabolic syndrome involves interactions between inflammatory pathways and ROS signaling [96] . Therefore, a link between oxidative stress and infrapatellar adipose tissue in knee OA is possible and needs further investigation.
Subchondral sclerosis is a major issue in OA pathogenesis and is involved in the pain generation in OA. In osteoblast of OA subchondral bone, hydroxinonenal (HNE) induces COX-2 expression and PGE2 release, by increasing the phosphorylation JNK2 and transcription factors binding factor-1(CREB-1) and activating transcription factor-2 (ATF-2) with a concomitant increase in the DNA-binding activity of CREB/ATF. Simultaneously, HNE decreased TNF-α-induced interleukin-6 (IL-6) expression. These findings suggest that ROS-induced HNE may exert multiple effects on human OA osteoblasts by selective activation of signal transduction pathways and alteration of osteoblastic phenotype expression and pro-inflammatory mediator production [97, 98] .
In addition, in an ovine meniscectomy model of OA, treatment with a NO -donor compound increases subchondral sclerosis, suggesting a role for NO -in the pain generation process in OA [99] . High levels of NO -inhibit osteoclast function and differentiation of osteoclasts from precursor cell types, as well as inhibiting osteoblast maturation and activity [100] . These observations suggest that oxidative stress has the potential be an important mediator of the subchondral bone changes seen in OA.
ROS and pain in OA
NO is involved in perception and reduction of pain caused by OA via four different pathways: 1) the blood-flow pathway is normalized in the presence of NO, which may help to decrease ischemic pain; 2) the nerve transmission pathway, which decreases the irritation of the nerves in the synovium, bone, and soft tissues; 3) the opioid receptor pathway, which might stimulate the body's normal pain reduction pathways; 4) and the anti-inflammation pathway.
Small amounts of transiently produced NO -, perhaps produced by eNOS, could potentially decrease the pain associated with OA [101] . Both H 2 O 2 and ONOO -are involved in pain deriving from inflammation, mainly through COX2/PGE2 pathway [102] .
Experimental model used to induce osteoarthritis
Animal models for OA are well established, and they serve as an important adjunct and surrogate for studies of OA in humans. These models provide a means to studying the pathophysiology of OA, and aid in the development of therapeutic agents and biological markers for diagnosing and prognosing disease. Small animal models are mainly used to study the pathogenesis and pathophysiology of the disease process. These models are relatively quicker, cheaper, and easier models to implement and study than the large animal models.
Chemically induced models mostly involve the injection of a toxic or inflammatory compound directly into the knee joint. This model can be used to study the effects of drugs on the inflammation or pain caused by these substances. Papain, sodium monoiodoacetate, quinolone, and collagenase are some of the chemicals employed to induce OA in animals. They eliminate the need for surgery and avoid possible infection issues in some animals. Their ease of induction and reproducibility are advantageous in designing short-term studies. Although less invasive than surgical models, chemical models have a unique pathophysiology which has no correlation to that of posttraumatic OA. This explains why they are mainly used to study the mechanism of pain and its use as a target for drug therapy.
Monosodium iodoacetate (MIA) is an inhibitor of glyceraldehyde-3-phosphate dehydrogenase activity, and causes dose-dependent cartilage degradation resembling the pathological changes of human osteoarthritis (OA).
MIA damages cartilage metabolism and leads to subchondral bone lesions and death of chondrocytes, and these OA-like lesions are similar to the pathologic changes seen in OA of humans [103] . MIA can result in cartilage matrix degradation and chondrocyte apoptosis in vivo and in vitro [104] .
Chondrocyte impairment (involving apoptosis and necrosis) breaks the balance between anabolism and catabolism in the extracellular matrix and plays a critical role in the progression of OA. Necrotic and proapoptotic properties of MIA have been demonstrated in rat chondrocytes in vitro, and preliminary data have established that caspase-dependent apoptosis occurs in MIA-induced OA in the rat. MIA induces cellular necrosis by blocking the energy production pathways. There are two main pathways can lead to apoptotic process, that is, the receptor (extrinsic) . Cellular response to ROS generation is dependent on the cellular redox status. In OA, oxidative stress degrades not only cellular membranes and nucleic acids but also extracellular components, leading to impaired biological activity, changes in protein structure and accumulation of damaged proteins in the tissue. Degradation products and cellular content containing oxidized molecules contribute to the exacerbation of synovial inflammation and form a vicious circle constituted by newly formed ROS and degradation products.
pathway and the mitochondrial (intrinsic) pathway. In the extrinsic pathway, the stimulus of cell death receptors (Fas, TNF-α, etc.) directly triggers caspase-3 initiating the following cascade reactions. In the intrinsic pathway, the apoptosis is initiated by response to a variety of stress signals. The classic signs of cell apoptosis are preceded by mitochondrial alterations including a decrease in energy production, a loss of membrane potential, an increase in the permeability of the mitochondrial membrane and a release of pro-apoptotic factors such as cytochrome C [105] .
The molecular mechanisms of apoptosis induced by MIA in chondrocytes of rat resulted in the reduction of membrane potential, the release of cytochrome c from mitochondrion, the activation of caspase-3 and finally the increase of apoptosis in primary rat chondrocytes.
ROS generation causes inflammation of articular cartilage and participates to apoptosis induction in OA [105, 106] . MIA promoted an increase of ROS level and a reduction in membrane potential level and ROS formation is the cause of the membrane potential alterations in primary rat chondrocytes treated with MIA. MIA promoted ROS production, led to the depolarization of membrane potential, further enhanced the release of cytochrome c and increased caspase-3 activity before leading to apoptosis. Also, oxidative stress plays an important upstream role in the apoptosis induced by MIA in primary rat chondrocytes [106] .
Concluding remarks
The signaling pathways by which ROS contribute to OA pathophysiology are complex and not fully understood. The progression of OA from silent cartilage destruction to painful clinical presentation is an important subject to further investigation. Due to their chemical properties, free radicals are apt to mediate and amplify the characteristic sequence of joint degeneration in all tissues affected. These properties make them a crucial factor involved in all joint tissues disease development and for the inflammatory transformation of OA joints. Therapeutic outcomes of these mechanisms may be a promising area for further research that may lead to a better understanding and therefore arrest of disease progression.
